These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2698643

  • 21. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
    Marcinkiewicz J, Szymanowska Z, Mazurek A.
    Przegl Lek; 1998; 55(11):611-3. PubMed ID: 10216377
    [Abstract] [Full Text] [Related]

  • 22. Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease.
    Ehara H, Kiyohara K, Izumisawa Y, Ito T.
    Cell Immunol; 2010; 265(1):57-64. PubMed ID: 20673885
    [Abstract] [Full Text] [Related]

  • 23. Immunological abnormalities and endothelial cell injury in Kawasaki disease.
    Nonoyama S.
    Acta Paediatr Jpn; 1991 Dec; 33(6):752-5. PubMed ID: 1801555
    [Abstract] [Full Text] [Related]

  • 24. [Imbalance among circulating T cell subsets and staining for HLA-DR antigen in coronary endothelial cells in Kawasaki disease].
    Terai M, Kohno Y, Niwa K, Umemiya T, Mikata A, Nakajima H.
    Arerugi; 1987 Jul; 36(7):394-403. PubMed ID: 3500695
    [No Abstract] [Full Text] [Related]

  • 25. Kawasaki disease: diagnosis, management, and long-term implications.
    Satou GM, Giamelli J, Gewitz MH.
    Cardiol Rev; 2007 Jul; 15(4):163-9. PubMed ID: 17575479
    [Abstract] [Full Text] [Related]

  • 26. [Current viewpoints in the pathogenesis of Kawasaki disease].
    Bollen CW, Rijkers GT, Zegers BJ, de Graeff-Meeder ER.
    Ned Tijdschr Geneeskd; 1995 Mar 18; 139(11):549-54. PubMed ID: 7700390
    [No Abstract] [Full Text] [Related]

  • 27. Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease.
    Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, Kobayashi Y, Yabuuchi H.
    Prog Clin Biol Res; 1987 Mar 18; 250():555-6. PubMed ID: 3321085
    [No Abstract] [Full Text] [Related]

  • 28. Can early treatment provide better prognosis in Kawasaki disease? A retrospective study on 616 children.
    Usami H, Harada K, Okuni M.
    Prog Clin Biol Res; 1987 Mar 18; 250():577-8. PubMed ID: 3423079
    [No Abstract] [Full Text] [Related]

  • 29. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease.
    Burns JC, Geha RS, Schneeberger EE, Newburger JW, Rosen FS, Glezen LS, Huang AS, Natale J, Leung DY.
    Nature; 1987 Mar 18; 323(6091):814-6. PubMed ID: 2430187
    [Abstract] [Full Text] [Related]

  • 30. Intravenous gamma globulin therapy in Kawasaki disease--trial of low dose gamma globulin.
    Okuni M, Harada K, Yamaguchi H, Yanagawa H, Sonobe T, Kawasaki T.
    Prog Clin Biol Res; 1987 Mar 18; 250():433-9. PubMed ID: 3321083
    [No Abstract] [Full Text] [Related]

  • 31. [Kawasaki disease. Immunological evaluation of 26 cases].
    Krasovec S, Bezrodnik L, Gaillard MI, Carabajal P, Ginaca A, Vainstein E.
    Medicina (B Aires); 2001 Mar 18; 61(1):8-14. PubMed ID: 11265631
    [Abstract] [Full Text] [Related]

  • 32. Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.
    Furukawa S, Matsubara T, Jujoh K, Sasai K, Nakachi S, Sugawara T, Yabuta K, Kato H.
    Eur J Pediatr; 1990 Nov 18; 150(1):43-7. PubMed ID: 1706665
    [Abstract] [Full Text] [Related]

  • 33. [Kawasaki disease--two case reports].
    Mroczkowska-Juchniewicz A, Moszyńska B, Pawłowska-Kamieniak A, Szczepanowska A, Papierkowski A.
    Pol Merkur Lekarski; 1997 Jul 18; 3(13):20-1. PubMed ID: 9432293
    [Abstract] [Full Text] [Related]

  • 34. Selection of high-risk children for immunoglobulin therapy in Kawasaki disease.
    Iwasa M, Sugiyama K, Ando T, Nomura H, Katoh T, Wada Y.
    Prog Clin Biol Res; 1987 Jul 18; 250():543-4. PubMed ID: 3423068
    [No Abstract] [Full Text] [Related]

  • 35. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr 18; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 36. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC, Aronoff SC.
    Pediatrics; 2005 Oct 18; 116(4):989-95. PubMed ID: 16199713
    [Abstract] [Full Text] [Related]

  • 37. Immunologic abnormalities in children with acute Kawasaki disease.
    Ding XT, Yang XQ, Li CR, Shen J.
    Chin Med J (Engl); 1993 Sep 18; 106(9):688-92. PubMed ID: 8287706
    [Abstract] [Full Text] [Related]

  • 38. [Kawasaki disease: recent findings in etiology, pathogenesis and therapy].
    Di Piero G, Bellisario G, Di Maggio M, Garibaldi G, Isola ML, Pauselli F, Proia R.
    Pediatr Med Chir; 1989 Sep 18; 11(2):209-17. PubMed ID: 2668907
    [Abstract] [Full Text] [Related]

  • 39. The diagnosis and management of Kawasaki disease.
    Royle J, Burgner D, Curtis N.
    J Paediatr Child Health; 2005 Mar 18; 41(3):87-93. PubMed ID: 15790316
    [Abstract] [Full Text] [Related]

  • 40. Kawasaki disease: a maturational defect in immune responsiveness.
    Kuijpers TW, Wiegman A, van Lier RA, Roos MT, Wertheim-van Dillen PM, Pinedo S, Ottenkamp J.
    J Infect Dis; 1999 Dec 18; 180(6):1869-77. PubMed ID: 10558943
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.